naphazoline has been researched along with Di Guglielmo Disease in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Excerpt | Relevance | Reference |
---|---|---|
"Even though the erythroleukemia cell lines K562 and HEL do not express α1-adrenoceptors, some α1-adrenergic drugs influence both survival and differentiation of these cell lines." | 1.37 | α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells. ( Fuchs, R; Haas, HS; Leitinger, G; Letofsky-Papst, I; Sadjak, A; Schauenstein, K; Schraml, E; Stelzer, I, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuchs, R | 2 |
Schraml, E | 2 |
Leitinger, G | 2 |
Stelzer, I | 2 |
Allard, N | 1 |
Haas, HS | 2 |
Schauenstein, K | 2 |
Sadjak, A | 2 |
Letofsky-Papst, I | 1 |
2 other studies available for naphazoline and Di Guglielmo Disease
Article | Year |
---|---|
α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Apopt | 2011 |
α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.
Topics: Adrenergic Agents; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Ag | 2011 |